Stock Rich List
#1383 on the rich list of 14,452 insiders

Brian Taylor Slingsby

Director at Mineralys Therapeutics. Based in Seattle, Washington.

$112M
in disclosed stock, +$3.0M (+2.76%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1383rd of 14,452
Companies held
1
Largest holding
MLYS, 100.0% of total
Latest SEC filing
Sep 22, 2026
Listed but not counted
$111M

What the $112M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Mineralys Therapeutics MLYS
Common Stock
Indirectly (see filing footnote)7,910,038$14.16$112M100.0%Form 4, Feb 19, 2026

Share counts are the amounts Brian Taylor Slingsby reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Brian Taylor Slingsby's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Mineralys Therapeutics MLYS
Common Stock
Through Catalys Pacific Fund, LP
Held by a company or fund the insider manages
7,805,718$14.16$111M—Form 4, Sep 22, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 22, 2026SoldMLYS104,320$28.81$3.0MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1380Charles V Bergh
Executive Vice Chair, Levi Strauss &. Oakland, CA
$112M−$2.6M (−2.25%)
1381Shizhong Ding
Director, Amer Sports
$112M−$5.5M (−4.65%)
1382George W. LeMaitre
Chairman and CEO, LeMaitre Vascular. Burlington, MA
$112M−$704K (−0.62%)
1383Brian Taylor Slingsby
Director, Mineralys Therapeutics. Seattle, WA
$112M+$3.0M (+2.76%)
1384Seth A. Ravin
President, CEO & Chairman, Rimini Street. Las Vegas, NV
$112M−$3.4M (−2.96%)
1385Mark Chin
Director, Enliven Therapeutics. Boston, MA
$112M+$4.1M (+3.76%)
1386Martin L. Flanagan
President & CEO, Invesco. Atlanta, GA
$112M−$3.5M (−3.07%)

Other Mineralys Therapeutics insiders

All MLYS insiders

Questions

How much stock does Brian Taylor Slingsby own?

Brian Taylor Slingsby holds $112,006,138 in listed stock based on SEC filings and current prices, mostly Mineralys Therapeutics (MLYS). That ranks 1383rd on the Stock Rich List.

Is this Brian Taylor Slingsby's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Brian Taylor Slingsby last buy or sell stock?

The most recent open-market trade on file is a sale of 104,320 MLYS shares on Sep 22, 2026 at $28.81.